Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Phase II, Randomized, Open-Labeled Study to Evaluate Low-Dose Pembrolizumab in Addition to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

Adhip Arora,V. Seenu,Rajinder Parshad,V. K. Bansal,Anita Dhar,Sandeep Mathur,Pranay Tanwar,Piyush Mishra,Kamal Kataria, Suhani,Ajay Gogia, Brijesh Kumar,K. P. Haresh,Supriya Mallick,Surendra Kumar Saini,Ashutosh Mishra,Babul Bansal,Jyoti Sharma,Jyoutishman Saikia,Krithika Rangarajan,Ekta Dhamija,Chandra Prakash Prasad, Shamim Ahmed Shamin, Sourabh Agastm, Kaushal Kalra, Divvay Vishvam,Kalaivani Mani,Akash Kumar,Sameer Bakhshi,Atul Batra

Trials（2025）

Cited 0|Views2
Key words
Triple negative,Breast cancer,Immunotherapy,Low dose,Pembrolizumab,Non-metastatic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined